Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,786.4 | 142.85 | 4,28,785.15 | 608.7 | 0.9 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,638.5 | 66.2 | 1,76,241.94 | 756 | 0.45 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,463.7 | 68.28 | 1,51,058.35 | 467 | 0.85 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,377 | 32.3 | 1,11,179.71 | 384.64 | 0.94 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,098.3 | 29.92 | 1,10,474.43 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.
Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
